1. Home
  2. STBX vs NVNO Comparison

STBX vs NVNO Comparison

Compare STBX & NVNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STBX
  • NVNO
  • Stock Information
  • Founded
  • STBX 2019
  • NVNO 1987
  • Country
  • STBX Malaysia
  • NVNO United States
  • Employees
  • STBX N/A
  • NVNO N/A
  • Industry
  • STBX Advertising
  • NVNO Medical/Dental Instruments
  • Sector
  • STBX Consumer Discretionary
  • NVNO Health Care
  • Exchange
  • STBX Nasdaq
  • NVNO Nasdaq
  • Market Cap
  • STBX 51.1M
  • NVNO 42.7M
  • IPO Year
  • STBX 2022
  • NVNO N/A
  • Fundamental
  • Price
  • STBX $0.14
  • NVNO $3.40
  • Analyst Decision
  • STBX
  • NVNO
  • Analyst Count
  • STBX 0
  • NVNO 0
  • Target Price
  • STBX N/A
  • NVNO N/A
  • AVG Volume (30 Days)
  • STBX 105.4K
  • NVNO 260.5K
  • Earning Date
  • STBX 10-29-2024
  • NVNO 10-28-2024
  • Dividend Yield
  • STBX N/A
  • NVNO N/A
  • EPS Growth
  • STBX N/A
  • NVNO N/A
  • EPS
  • STBX N/A
  • NVNO N/A
  • Revenue
  • STBX $12,213,183.00
  • NVNO N/A
  • Revenue This Year
  • STBX N/A
  • NVNO N/A
  • Revenue Next Year
  • STBX N/A
  • NVNO N/A
  • P/E Ratio
  • STBX N/A
  • NVNO N/A
  • Revenue Growth
  • STBX 48.08
  • NVNO N/A
  • 52 Week Low
  • STBX $0.10
  • NVNO $3.01
  • 52 Week High
  • STBX $0.79
  • NVNO $6.97
  • Technical
  • Relative Strength Index (RSI)
  • STBX 42.53
  • NVNO 36.77
  • Support Level
  • STBX $0.12
  • NVNO $3.10
  • Resistance Level
  • STBX $0.13
  • NVNO $3.40
  • Average True Range (ATR)
  • STBX 0.01
  • NVNO 0.16
  • MACD
  • STBX 0.00
  • NVNO 0.08
  • Stochastic Oscillator
  • STBX 51.72
  • NVNO 79.91

About STBX Starbox Group Holdings Ltd.

Starbox Group Holdings Ltd engages in developing cash rebate, digital advertising, and payment solution business ecosystem targeting micro, small, and medium enterprises. Through the firm's subsidiaries in Malaysia, it connects retail merchants with retail shoppers to facilitate transactions through cash rebates offered by retail merchants, provide digital advertising services to advertisers, and provide payment solution services to merchants. Substantially all of its current operations are located in Malaysia. It operates in five segments include Cash rebate, payment solution, and media booking, Advertising services, Software licensing and Production services, Marketing and Promotional campaign services segment.

About NVNO enVVeno Medical Corporation

enVVeno Medical Corp is a medical device company focused on the development of bioprosthetic (tissue-based) devices to improve the standard of care in the treatment of venous disease. Its product, the VenoValve, is a first-in-class, surgical implant being developed for the treatment of severe deep venous Chronic Venous Insufficiency (CVI).

Share on Social Networks: